Français
ItalianoBond Pfizer 4.5% ( US717081FE83 ) in USD
| Issuer | Pfizer | ||||||||
| Market price |  100.07 % ▲ |
||||||||
| Country |  United States
|
||||||||
| ISIN code |
 US717081FE83 ( in USD )
|
||||||||
| Interest rate | 4.5% per year ( payment 2 times a year) | ||||||||
| Maturity | 15/11/2032 | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | / | ||||||||
| Total amount | / | ||||||||
| Cusip | 717081FE8 | ||||||||
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) | ||||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||||
| Next Coupon | 15/11/2026 ( In 83 days ) | ||||||||
| Detailed description |
Pfizer is a multinational pharmaceutical and biotechnology company headquartered in New York City that researches, develops, manufactures, and markets drugs and vaccines globally. The Bond issued by Pfizer ( United States ) , in USD, with the ISIN code US717081FE83, pays a coupon of 4.5% per year. The coupons are paid 2 times per year and the Bond maturity is 15/11/2032 The Bond issued by Pfizer ( United States ) , in USD, with the ISIN code US717081FE83, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Pfizer ( United States ) , in USD, with the ISIN code US717081FE83, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||